ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA

Fenqi, Du; Yupeng, Liu; Qiuju, Zhang; Chao, Yuan; Wenjie, Song; Tianyi, Xia; Junnan, Guo; Weinan, Xue; Xiufeng, Jiang; Junge, Bai; Chenyang, Jia; Hua, Xi; Yien, Li; Xuefeng, Bai; Yanlong, Liu哈尔滨医科大学
Frontiers in Oncology2022-1-11DOI: 10.3389/fonc.2021.758509
8被引8阅读
引用收藏
分享

摘要

BackgroundSerum carcinoembryonic antigen (CEA) is an important biomarker for diagnosis, prognosis, recurrence, metastasis monitoring, and the evaluation of the effect of chemotherapy in colorectal cancer (CRC). However, few studies have focused on the role of early postoperative CEA in the prognosis of stage II CRC. MethodsPatients with stage II CRC diagnosed between January 2007 and December 2015 were included. Receiver operating characteristic (ROC) curves were used to obtain the cutoff value of early postoperative CEA, CEA ratio and CEA absolute value. The areas under curves (AUCs) were used to estimate the predictive abilities of the CEA and T stage. The stepwise regression method was used to screen the factors included in the Cox regression analysis. Before and after propensity score (PS) - adjusted Cox regression and sensitivity analysis were used to identify the relationship between early postoperative CEA and prognosis. Meta-analysis was performed to verify the results. Kaplan-Meier survival curves were used to estimate the effects of CEA on prognosis. ResultsWe included 1081 eligible patients. ROC curves suggested that the cutoff value of early postoperative CEA was 3.66 ng/ml (P <0.001) and the AUC showed early postoperative CEA was the most significant prognostic marker in stage II CRC (P = 0.0189). The Cox regression and sensitivity analysis before and after adjusting for PS both revealed elevated early postoperative CEA was the strongest independent prognostic factor of OS, DFS, and CSS (P < 0.001). Survival analysis revealed that patients with elevated early postoperative CEA had lower OS (53.62% VS 84.16%), DFS (50.03% VS 86.75%), and CSS (61.77% VS 90.30%) than patients with normal early postoperative CEA (P < 0.001). When the postoperative CEA was positive, the preoperative CEA level showed no significant effect on the patient's prognosis (all P-values were > 0.05). Patients with a CEA ratio <= 0.55 or CEA absolute value <=-0.98 had a worse prognosis (all P-values were < 0.001). Survival analysis suggested that adjuvant chemotherapy for stage II CRC patients with elevated early postoperative CEA may improve the CSS (P = 0.040). ConclusionsEarly postoperative CEA was a better biomarker for prognosis of stage II CRC patients than T stage and preoperative CEA, and has the potential to become a high-risk factor to guide the prognosis and treatment of stage II CRC patients.

学科与关键词

关键词
Postoperative serum carcinoembryonic antigenstage II colorectal cancerprognosishigh-risk factoradjuvant chemotherapy
相关
加载中…
  • Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer
    Wang, Ren; Xu, Benjie; Sun, Mingming; Pang, Xiangyi; Wang, Xin; Zhu, Jiahao; Lian, Jie*; Lu, Haibo*EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 49(12): 107138.
  • Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis
    Zhou, Huabin; Wang, Songsheng; Cai, Zhai; Qiu, Enming; Chen, Qianyun; Rao, Xi; Han, Shuai; Li, Zhou*INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37(12): 2481-2489.
  • Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
    Pang, Xiangyi; Xu, Benjie; Lian, Jie; Wang, Ren; Wang, Xin; Shao, Jiayue; Tang, Shuli; Lu, Haibo*Frontiers in Oncology, 2022, 12: 914076.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-01-11
卷期
第 11 卷
页码
758509
DOI
10.3389/fonc.2021.758509
期刊等级
3区
成果收录
SCIE
资助标注
Harbin Medical University Cancer Hospital Preeminence Youth Fund [JCQN2019-04]; Medical Wisdom Research Fund by the Heilongjiang Sunshine Health Foundation [H21L0802]

作者

  • F

    Fenqi, Du (第一作者)

    harbin med univ

  • Y

    Yupeng, Liu

    wenzhou med univ

查看全部 15 位作者收起作者
  • Q

    Qiuju, Zhang

    harbin med univ

  • C

    Chao, Yuan

    harbin med univ

  • W

    Wenjie, Song

    harbin med univ

  • T

    Tianyi, Xia

    harbin med univ

  • J

    Junnan, Guo

    harbin med univ

  • W

    Weinan, Xue

    harbin med univ

  • X

    Xiufeng, Jiang

  • J

    Junge, Bai

    harbin med univ

  • C

    Chenyang, Jia

    harbin med univ

  • H

    Hua, Xi

    harbin med univ

  • Y

    Yien, Li

    harbin med univ

  • X

    Xuefeng, Bai

    harbin med univ

  • Y

    Yanlong, Liu

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417